BioWorld-International-2002-01-30

No Abstract

No Abstract

No Abstract

No Abstract

No Abstract

No Abstract

PARIS UroGene SA entered into a three-year research collaboration with Pierre Fabre M dicament to discover and develop new active compounds to treat prostate cancer against a validated biological target identified by UroGene. (BioWorld International)

No Abstract

No Abstract

No Abstract